High levels of SLAMF7 were reported in hematologic malignancies such as chronic lymphocytic leukemia, diffuse large B-cell lymphoma, multiple myeloma, and myelodysplastic syndromes [13, 35]. This evidence concerns the gene SLAMF7 and hematologic disorder.